Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2020) Milena Gianfrancesco et al.   ANNALS OF THE RHEUMATIC DISEASES

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

(2020) Erica J. Brenner et al.   GASTROENTEROLOGY

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

(2020) Annemarie B Docherty et al.   BMJ-British Medical Journal

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic

(2020) Ted R. Mikuls et al.   Arthritis & Rheumatology

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

(2020) Jose L Pablos et al.   ANNALS OF THE RHEUMATIC DISEASES

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice

(2020) Jean W Liew et al.   RHEUMATOLOGY

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

(2020) Xabier Michelena et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis

(2020) Michael Putman et al.   Arthritis & Rheumatology

Incidence of COVID‐19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?

(2020) Ennio Giulio Favalli et al.   Arthritis & Rheumatology

Sulfasalazine as an Immunomodulator of the Inflammatory Process during HIV-1 Infection

(2019) Manuel G. Feria-Garzón et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Methotrexate an Old Drug with New Tricks

(2019) Yosra Bedoui et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The role of adjuvant immunomodulatory agents for treatment of severe influenza

(2018) David S. Hui et al.   ANTIVIRAL RESEARCH

In vitro modeling of HIV proviral activity in microglia

(2017) Lee A. Campbell et al.   FEBS Journal

Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques

(2016) Ivona Pandrea et al.   PLoS Pathogens

Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis

(2015) A Richter et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

(2010) J. B. Galloway et al.   RHEUMATOLOGY